According to a new report, published by KBV research, The Global data monetization solutions for life science companies market size is expected to reach $1.07 billion by 2031, rising at a market growth of 16.1% CAGR during the forecast period.
The Direct Data Monetization segment registers a CAGR of 16.8% during (2024 - 2031). This segment involves directly selling or exchanging data, where life science companies generate revenue by licensing or selling their data to external organizations or stakeholders. The growing emphasis on real-time insights, data-driven decision-making, and collaborations with research institutions or healthcare providers has fueled the expansion of direct data monetization. Companies increasingly leverage their proprietary data sets to unlock new revenue streams, making this segment a significant contributor to the overall market’s growth.
The Large Facilities segment is leading the Global data monetization solutions for life science companies by Facility Size in 2023, thereby, achieving a market value of $645.76 million by 2031. The large facilities segment has a high revenue share, indicating the dominant role that larger life science companies and organizations play in adopting data monetization solutions. These large facilities often have extensive data infrastructure, making them well-positioned to leverage advanced tools and technologies to extract value from large datasets.
The On-Premises segment is experiencing a CAGR of 16.7% during (2024 - 2031). While on-premises solutions provide more control over data security, privacy, and compliance, they often require significant capital investment and ongoing maintenance. These solutions tend to be favored by life science companies with more stringent data governance requirements or those operating in regions with specific regulatory frameworks. Although the cloud segment continues to dominate the market, the on-premises segment still holds a substantial share due to the ongoing need for secure, localized data management solutions in certain sectors of the life sciences industry.
Full Report: https://www.kbvresearch.com/data-monetization-solutions-for-life-science-companies-markett/
The North America region dominated the Global data-monetization-solutions-for-life-science-companies-market by Region in 2023; thereby, achieving a market value of $401.40 million by 2031. The Europe region is capturing a CAGR of 15.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 16.7% during (2024 - 2031).
By Type
By Facility Size
By Mode of Deployment
Unique Offerings 
